The antidiabetic drug metformin: a pharmaceutical AMPK activator to overcome breast cancer resistance to HER2 inhibitors while decreasing risk of cardiomyopathy
(Q46157399)
scientific article published on 19 January 2009
scientific article published on 19 January 2009
Language:
Current Data About
The antidiabetic drug metformin: a pharmaceutical AMPK activator to overcome breast cancer resistance to HER2 inhibitors while decreasing risk of cardiomyopathy
other details
| description | scientific article published on 19 January 2009 |
External Links
| (P356) |
10.1093/ANNONC/MDN758
|
| (P698) |
19153119
|